The company has three (3) issued U.S. Patents for systems/methods/devices to clean stethoscopes  (and other equipment) and has other U.S. patents-pending, all of which are to address the need to reduce hospital/facility acquired infections (“HAIs”) in hospitals, extended care facilities, nursing homes, infusion centers, ambulatory surgery centers, and other medical facilities of all kinds. The goal is to combine hand hygiene with stethoscope hygiene in a rapid (40 seconds or less) UV-light cleaning process that is fully-documented in hospital/facility databases and patient EMRs.

The entire system/method/devices will be developed in phases: a) Phase One - development of a UV-light stethoscope cleaning Beta device with a cleaning cycle of not more than 40 seconds (during which the Practitioner can engage in hand hygiene and speak to the patient). The Beta device is complete, microbiology tested, kills 99%-99.9% of pathogens, and is now being field tested for user feedback, to be followed by further device development: b) Phase Two - further device development will also include combining a hand-hygiene dispenser so that hand and stethoscope cleaning can occur at one location, and initial software and initial software AI. The rapid hand and stethoscope cleaning event will be documented/recorded in hospital/facility databases and EMR. The absence of such cleaning documentation at the time of patient examination will result in notifications to the Practitioner and/or Compliance Officer and other hospital/facility departments: c) Phase Three - the cleaning device will accommodate other equipment and devices for rapid cleaning and, where appropriate, documentation of the cleaning event. A current plugged-in Beta unit was developed using a team of UV light experts, biomedical engineers, medical product developers, and physicians. The Beta unit was tested by the team, a microbiology laboratory, and separate testing took place as to the effect of the UV-light rapid exposure on the tubing and ear pieces (no significant adverse effects were found). The team confirmed that the stethoscope cleaning Beta device would run efficiently on battery power.

The company calls the current Beta stethoscope cleaning device “oeUVre” which means “work of art” and is customarily used to describe the substantial body of work of a writer, composer, or artist.

Jonnat Management Corp. has been issued three (3) U.S. Patents: (US 9,918,803 and US 10,500,016 and U.S. Patent 10,973,605, generally, provide for: 1) a cleaning device wherein the entire stethoscope (or alternatively the bell and diaphragm of the stethoscope) are received, 2) the device cleans and monitors the cleaning process and collects, records, and transmits data (cleaning and identification of the healthcare provider) to the EMR and to a facility database, 3) the cleaning device accommodates a variety of hand cleaning modalities for either stethoscope alone or simultaneous cleaning of hands and stethoscopes, data collection/transfer as to both, as well as accommodating the cleaning and data collection of other medical equipment, 4) with no limitation on the physical shape or size of the device(s), 5) with cleaning accomplished through UV light or other means, and 6) the system/method includes the overall system and multiple connected cleaning devices networked or connected to a database, and 7) software/AI in connection with the use of the data. The U.S. Patents cover the system/method and the device(s) needed to accomplish the system/method to achieve compliance with protocols and requirement. As of the writing of this document, Jonnat Management Corp. has two (2) additional pending U.S. Patent applications, one covering the Beta stethoscope cleaning device.